An observational study in Nasal High Flow Therapy, Intensive Care Unit and Ventilatory Failure, sponsored by Fundación Santa Fe de Bogota. Status unknown at 9 sites in 4 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-08-12.
Sponsored by Fundación Santa Fe de Bogota · Observational
The study aims to describe the use of Nasal High Flow (NHF) in the intensive care units of participating centers in Iberoamerica. It will describe the indications for the use, the clinical outcome of patients , and the therapeutic failure of NHF therapy in patients staying in an intensive care unit in the participant centers in Iberoamerica.
96 studies on the registry are indexed under Hypoventilation; 21 are open to participants now.
This study's planned enrollment of 255 is above the median of 74 across 28 observational studies indexed under Hypoventilation.
Browse Hypoventilation studies →Fundación Santa Fe de Bogota is the lead sponsor of 27 studies on the registry; 11 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients over 18 years old, admitted to an ICU in the reference centers in Iberoamerica, requiring the use of high nasal flow therapy
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Every patient in the ICU that requires High Nasal Flow Therapy
Other: No intervention
No intervention, observational study
Hypoxemia
PO2 under 60mmHg, or SatO2 under 80%; that leads to the instauration of invasive ventilation
Time frame: 15 days
Tachypnea
Respiratory rate over 20; that leads to the instauration of invasive ventilation
Time frame: 15 days
Hypercapnia
PCO2 over 55mmHg; that leads to the instauration of invasive ventilation
Time frame: 15 days
Plan to share: No — No IPD will be available to external researchers prior to publication
No publications or documents are linked to this record.
This study is status unknown, as verified in Aug 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Fundación Santa Fe de Bogota